A Baldoni, A G Cosco, G Epicoco, G Affronti, E Giannone, G Gilardi
Index: Minerva Ginecol. 41(3) , 149-55, (1989)
Full Text: HTML
The results obtained in 80 patients hospitalized at the University of Obstetrics and Gynecology Clinic in Perugia for abdominal and vaginal hysterectomy are reported and evaluated in a prospective and randomized study of perioperative antibacterial prophylaxis. In the 75 patients available to study a single intravenous dose of 2 g cefotetan was compared with a triple dose of 1 g intravenous cephazolin. A reduction in the incidence of post-operative infections both in abdominal hysterectomy from 24% (cephazolin group) to 11.53% (cefotetan group) and in vaginal hysterectomy from 40% (cephazolin group) to 71.4% (cefotetan group) was noted. These results show that a single intravenous dose of 2 g cefotetan can be considered a valid therapeutic support for antibacterial prophylaxis. In addition the absence of alterations in the parameters considered (haematological, biochemical and urinary) points to the safety, effectiveness and non-toxicity of the drug.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Cefazolin
CAS:25953-19-9 |
C14H14N8O4S3 |
Isolation of Escherichia coli strains with AcrAB-TolC efflux...
2014-07-01 [J. Vet. Med. Sci. 76(7) , 937-45, (2014)] |
Aspiration sclerotherapy combined with pasireotide to improv...
2015-01-01 [Trials 16 , 82, (2015)] |
Skeletal muscle and plasma concentrations of cefazolin durin...
2014-12-01 [J. Thorac. Cardiovasc. Surg. 148(6) , 2634-41, (2014)] |
National surveillance study on carbapenem non-susceptible Kl...
2013-01-01 [PLoS ONE 8(7) , e69428, (2013)] |
Once-daily cefazolin and probenecid for skin and soft tissue...
2004-03-01 [Ann. Pharmacother. 38(3) , 458-63, (2004)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved